Overview

Vantage Biotech is a leading company specializing in endoscopic spine surgery solutions. Since our establishment in 2011, we have been dedicated to supplying cutting-edge endoscopes, complemented by a range of instruments tailored for both uniportal and biportal techniques. Our product portfolio also features a high-speed drill system and an advanced radiofrequency system, all meticulously engineered to address the evolving needs and trends worldwide.

Vision and Culture

  • Vision: Leveraging advantages of the endoscope technology and AI advancements, Vantage Biotech is committed to continuous learning and innovative design to create diverse value in spinal endoscopic solutions.
  • Culture: Stay sharp, youthful, innovative, and scientific-orientated. Vantage Biotech is dedicated to cultivating both uniportal and biportal endoscopes and instruments in an innovative design. With energetic and professional prospective, we continuously explore endoscopic products based on the market demand. Additionally, we aim to enhance our business model through an optimized supply chain.

History (Milestone)

Vantage Biotech has been a key player in Taiwan's medical sector for over a decade, combining German expertise with local insights. We focus on spinal surgery, as well as minimally invasive surgery (MIS) systems. Our extensive portfolio includes a wide range of advanced products, services, and procedures, all designed to address the future needs of the medical market.

Our team of specialists in spinal endoscopy is dedicated to upholding international standards and protocols. We adhere to both CE and FDA regulations, ensuring that our solutions meet the highest benchmarks for safety and effectiveness.

 
 
  • 2011-05
    JiaXin Biotech
    JiaXin Biotech was founded and specialized in spine surgery related devices and consumables.
  • 2013-10
    Spinendos
    Spinendos our exclusive distributor in Taiwan
  • 2014-10
    TFDA
    Granted for all endoscopy instruments and consumables.
  • 2019-05
    Global Sales
    Global Sales in Malaysia, partening up with Prime Medical Concepts.
  • 2021-12
    Vantage Biotech
    was launched, focusing on spinal endoscopy solutions and aiming to provide quality products for surgeons to enhance surgery effectiveness and outcomes.
  • 2022-01
    Large Market Share in Taiwan
    in spinal endoscopy market in Taiwan as one of the strongest players
  • 2023-01
    International Market
    Expanding international market with our own brand “VantageBiotech” in 2023.
    - Hong Kong 2023-10
    - Phillipines 2024-12

Team

At Vantage Biotech, our team is driven by initiative and insight. We prioritize continuous professional development through regular on-the-job training, aligned with national recommendations. This commitment ensures that our team members stay both dynamic and proficient, maintaining a competitive edge in the evolving market.

Future

Maintaining close communication with surgeons and medical professionals around the world has driven our continual growth. Utilizing German steel technology, we produce unique spinal endoscopes, surgical instruments, and equipment of the highest quality. At Vantage Biotech, we always prioritize the best interests of our clients. We have established a training program based in South Korea, where we offer training courses to gather feedback from doctors and improve our product technology and quality. This allows us to deliver surgeries that are both safe and effective, along with high-quality service.